NASDAQ:BTAI

BioXcel Therapeutics Earning Date

USA |NASDAQ |USD

BTAI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-1.05 $-1.11 $-1.07
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $14.10K $0.01

Bioxcel Therapeutics's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

BTAI Earnings Date & History Chart

BTAI Earnings & Revenue Forecast

BTAI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.19 $-1.54 $-0.95
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $-4.40 $-5.06 $-3.64
Dec 2022 11 $-4.00 $-7.01 $-1.10

BTAI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.19 $-1.23 $-1.26
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-4.40 $-4.48 $-4.52
Dec 2022 0 / 0 $-4.00 $-4.05 $-3.87

BTAI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $0.00 $0.00 $0.00
Dec 2022 11 $61.69M $2.80M $126.00M

BTAI Earnings Date & Revenue History

BTAI Earnings History

|
Show More
Show More

BTAI Revenue History

|
Show More
Show More

Bioxcel Therapeutics Next Earnings Date & Report

BTAI Next Earnings Date & Report Preview: Sep 2021 (FQ)

BTAI's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Bioxcel Therapeutics's next quarterly earnings is $-1.05, with a low EPS estimation of $-1.26, and a high estimation of $-0.87.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.05, the last 2 month trend is $-1.11, and the 3 month trend is $-1.13.

Based on 7 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Bioxcel Therapeutics Previous Earnings Dates & Reports

BTAI Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bioxcel Therapeutics's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

BTAI's earnings per share (EPS) was $-1.11, missing the consensus analysts forecast of $-1.05 by -6.04%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 2.78%, and lower than the same period a year before (Jun 2020) by 4.72%.

Revenues were $14.10K.

The company reported a net income of $-27.62M.

Free cash flow for the quarter was $-22.48M , compared to $-19.96M last quarter and $-14.86M a year before.

BTAI ended the quarter with $1.25M in total debt, a decrease of -5.50% compared to the previous quarter, and an increase of 38.37% compared to the same quarter a year before.

BTAI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bioxcel Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

BTAI's earnings per share (EPS) was $-3.79, beating the consensus analysts forecast of $-3.86 by -1.81% , and lower than the previous year's EPS (Dec 2019) by 87.62%.

Revenues were $24.30.

The company reported a net income of $-82.17M.

Bioxcel Therapeutics reported a free cash flow of $-66.67M for its fiscal year, compared to $-28.15M a year ago.

The company ended the fiscal year with $1.40M in total debt, an increase of 35.86% compared to the previous year.